Lidocaine Hydrochloride Inje · #4 of 35 active shortages by FDA posting duration
FDA lists Lidocaine Hydrochloride Inje as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Unavailable
Lidocaine Hydrochloride Injection: Active Shortage
Unavailable 71 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Lidocaine Hydrochloride Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34)
- Package NDC
- 0409-4903-34
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Feb 22, 2012
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Anesthesia, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
lidocaine topical
Side effects, interactions, warnings & more
Nearby, Other Lidocaine Shortage Records
Lidocaine Hydrochloride Injection
Sintetica US
Injection
Lidocaine Hydrochloride Injection
Sintetica US
Injection
Lidocaine Hydrochloride Injection
Sintetica US
Injection
Lidocaine Hydrochloride Injection
Sintetica US
Injection
Lidocaine Hydrochloride Injection
Sintetica US
Injection
Lidocaine Hydrochloride Injection
Sintetica US
Injection
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.